Loading...
Bonesupport Holding AB (publ)
0RQO.L•LSE
Healthcare
Medical - Pharmaceuticals
£315.89
£-9.69(-2.98%)
Bonesupport Holding AB (publ) (0RQO.L) Financial Performance & Statements
Review Bonesupport Holding AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
52.05%
↑ 52.05%
Operating Income Growth
1092.73%
↑ 1092.73%
Net Income Growth
-45.41%
↓ 45.41%
Operating Cash Flow Growth
460.19%
↑ 460.19%
Operating Margin
16.49%
↑ 16.49%
Gross Margin
92.60%
↑ 92.60%
Net Profit Margin
12.26%
↑ 12.26%
ROE
17.73%
↑ 17.73%
ROIC
22.02%
↑ 22.02%
Bonesupport Holding AB (publ) (0RQO.L) Financial Statements
Explore quarterly and annual reports for Bonesupport Holding AB (publ) stock.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $283.54M | $257.01M | $237.50M | $219.79M |
Cost of Revenue | $21.007M | $18.98M | $16.87M | $17.00M |
Gross Profit | $262.54M | $238.03M | $220.63M | $202.79M |
Gross Profit Ratio | $0.93 | $0.93 | $0.93 | $0.92 |
R&D Expenses | $23.81M | $21.84M | $19.68M | $20.32M |
SG&A Expenses | $129.45M | $131.44M | $153.74M | $152.76M |
Operating Expenses | $232.89M | $173.81M | $179.67M | $173.08M |
Total Costs & Expenses | $253.90M | $192.79M | $196.54M | $190.08M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $349000.00 | $209000.00 |
Depreciation & Amortization | $1.84M | $1.27M | $1.88M | $1.90M |
EBITDA | $31.47M | $65.48M | $42.84M | $31.62M |
EBITDA Ratio | $0.11 | $0.25 | $0.18 | $0.14 |
Operating Income | $29.65M | $64.22M | $40.96M | $29.71M |
Operating Income Ratio | $0.10 | $0.25 | $0.17 | $0.14 |
Other Income/Expenses (Net) | -$16.56M | $7.85M | -$349000.00 | -$1.25M |
Income Before Tax | $13.09M | $72.07M | $40.61M | $28.47M |
Income Before Tax Ratio | $0.05 | $0.28 | $0.17 | $0.13 |
Income Tax Expense | $2.66M | $18.16M | $10.04M | $1.04M |
Net Income | $10.43M | $53.91M | $30.57M | $27.43M |
Net Income Ratio | $0.04 | $0.21 | $0.13 | $0.12 |
EPS | $0.16 | $0.82 | $0.46 | $0.42 |
Diluted EPS | $0.16 | $0.81 | $0.46 | $0.41 |
Weighted Avg Shares Outstanding | $65.86M | $65.83M | $65.76M | $65.72M |
Weighted Avg Shares Outstanding (Diluted) | $66.82M | $66.82M | $66.74M | $66.69M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan